These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15991303)

  • 41. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
    Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
    Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.
    Heathcote EJ; Shiffman ML; Cooksley WG; Dusheiko GM; Lee SS; Balart L; Reindollar R; Reddy RK; Wright TL; Lin A; Hoffman J; De Pamphilis J
    N Engl J Med; 2000 Dec; 343(23):1673-80. PubMed ID: 11106716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment.
    Valla DC; Chevallier M; Marcellin P; Payen JL; Trepo C; Fonck M; Bourliere M; Boucher E; Miguet JP; Parlier D; Lemonnier C; Opolon P
    Hepatology; 1999 Jun; 29(6):1870-5. PubMed ID: 10347132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.
    Mandorfer M; Kozbial K; Freissmuth C; Schwabl P; Stättermayer AF; Reiberger T; Beinhardt S; Schwarzer R; Trauner M; Ferlitsch A; Hofer H; Peck-Radosavljevic M; Ferenci P
    Aliment Pharmacol Ther; 2015 Sep; 42(6):707-18. PubMed ID: 26179884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis.
    Meissner EG; Kohli A; Virtaneva K; Sturdevant D; Martens C; Porcella SF; McHutchison JG; Masur H; Kottilil S
    J Viral Hepat; 2016 Jul; 23(7):496-505. PubMed ID: 26840694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy of standard antiviral therapy retreatment following interferon treatment failure in chronic hepatitis C patients].
    Liu JP; Kang Y; Shang J; Ding GQ; Xiao EH; Wei JF; Cao Q
    Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):656-8. PubMed ID: 24160338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodynamics in the portal vein evaluated by pulse wave Doppler ultrasonography in patients with chronic hepatitis C treated with interferon.
    Nakanishi S; Shiraki K; Yamamoto K; Koyama M; Kimura N; Nakano T
    World J Gastroenterol; 2005 Jan; 11(3):396-9. PubMed ID: 15637752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies.
    Duong FH; Trincucci G; Boldanova T; Calabrese D; Campana B; Krol I; Durand SC; Heydmann L; Zeisel MB; Baumert TF; Heim MH
    J Exp Med; 2014 May; 211(5):857-68. PubMed ID: 24752298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system.
    Bellecave P; Sarasin-Filipowicz M; Donzé O; Kennel A; Gouttenoire J; Meylan E; Terracciano L; Tschopp J; Sarrazin C; Berg T; Moradpour D; Heim MH
    Hepatology; 2010 Apr; 51(4):1127-36. PubMed ID: 20044805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the endogenous interferon system, expression of interferon-alpha receptors, and response to interferon therapy in chronic hepatitis C.
    Pirisi M; Fabris C; Soardo G; Bartoli E
    J Hepatol; 1997 Oct; 27(4):768-9. PubMed ID: 9365057
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of 125I-interferon-alpha binding to peripheral blood cells from African-Americans and Caucasians with hepatitis C.
    Kimball P; Verbeke S; Shiffman M
    J Viral Hepat; 2003 Sep; 10(5):354-9. PubMed ID: 12969187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical particularities and response to the anti-inflammatory effect of antiviral treatment in patients with chronic hepatitis C and rheumatoid syndrome.
    Lilea GC; Streba CT; Baloseanu CL; Vere CC; Rogoveanu I
    J Med Life; 2012 Dec; 5(4):439-43. PubMed ID: 23346247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature.
    Nadir A; Amin A; Chalisa N; van Thiel DH
    J Viral Hepat; 2000 Nov; 7(6):466-70. PubMed ID: 11115059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.
    Barton AL; Banner BF; Cable EE; Bonkovsky HL
    Am J Clin Pathol; 1995 Apr; 103(4):419-24. PubMed ID: 7537017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients.
    Yamaguchi Y; Hino K; Fujiwara D; Ren F; Katoh Y; Satoh Y; Okita K
    Dig Dis Sci; 2002 Jul; 47(7):1611-7. PubMed ID: 12141824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic pathological features in naïve patients with chronic hepatitis C who have developed thyroid disorder.
    Biciuşcă V; Popescu M; Petrescu IO; Stan IS; Durand P; Petrescu M; Velea R; Traşcă DM; Popescu IAS; Udriştoiu I; Mărginean CM; Tudoraşcu DR; Petrescu F
    Rom J Morphol Embryol; 2020; 61(4):1085-1097. PubMed ID: 34171058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon receptor alpha/beta is associated with improved survival after adjuvant therapy in resected pancreatic cancer.
    Saidi RF; Remine SG; Jacobs MJ
    HPB (Oxford); 2007; 9(4):289-94. PubMed ID: 18345307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HCV and C282Y: a sinister synergism?
    Russo M; Grimm IS
    Gastroenterology; 1999 Feb; 116(2):494-5. PubMed ID: 9922334
    [No Abstract]   [Full Text] [Related]  

  • 60. Interferon-alpha improves bone resorption and osteopenia in patients with chronic hepatitis C.
    Nishida N; Komatsu Y; Komeda T; Fukuda Y
    Hepatol Res; 2006 Apr; 34(4):222-7. PubMed ID: 16516539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.